Micelle containing epirubicin-complexed block copolymer and anti-cancer agent, and pharmaceutical composition containing said micelle applicable to treatment of cancer, resistant cancer or metastatic cancer
US10220026B2 · kind B2 · utility
1Cited by
1References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 11, 2015 |
| Grant date | Mar 5, 2019 |
| Priority date | — |
| Expiry date | Aug 11, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The problem addressed by the present invention is to develop a pharmaceutical having therapeutic efficacy against epirubicin-resistant tumors. The present invention provides a micelle having an anti-cancer agent disposed inside the core of the micelle formed by an epirubicin-conjugated copolymer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.